These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

375 related articles for article (PubMed ID: 33488599)

  • 1. Interleukin-8 as a Biomarker for Disease Prognosis of Coronavirus Disease-2019 Patients.
    Li L; Li J; Gao M; Fan H; Wang Y; Xu X; Chen C; Liu J; Kim J; Aliyari R; Zhang J; Jin Y; Li X; Ma F; Shi M; Cheng G; Yang H
    Front Immunol; 2020; 11():602395. PubMed ID: 33488599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detectable Serum Severe Acute Respiratory Syndrome Coronavirus 2 Viral Load (RNAemia) Is Closely Correlated With Drastically Elevated Interleukin 6 Level in Critically Ill Patients With Coronavirus Disease 2019.
    Chen X; Zhao B; Qu Y; Chen Y; Xiong J; Feng Y; Men D; Huang Q; Liu Y; Yang B; Ding J; Li F
    Clin Infect Dis; 2020 Nov; 71(8):1937-1942. PubMed ID: 32301997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An inter-correlated cytokine network identified at the center of cytokine storm predicted COVID-19 prognosis.
    Liu Y; Chen D; Hou J; Li H; Cao D; Guo M; Ling Y; Gao M; Zhou Y; Wan Y; Zhu Z
    Cytokine; 2021 Feb; 138():155365. PubMed ID: 33246770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Using IL-2R/lymphocytes for predicting the clinical progression of patients with COVID-19.
    Hou H; Zhang B; Huang H; Luo Y; Wu S; Tang G; Liu W; Mao L; Mao L; Wang F; Sun Z
    Clin Exp Immunol; 2020 Jul; 201(1):76-84. PubMed ID: 32365221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High Levels of Circulating IL-8 and Soluble IL-2R Are Associated With Prolonged Illness in Patients With Severe COVID-19.
    Ma A; Zhang L; Ye X; Chen J; Yu J; Zhuang L; Weng C; Petersen F; Wang Z; Yu X
    Front Immunol; 2021; 12():626235. PubMed ID: 33584733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosis of SARS-CoV-2 infection in the setting of the cytokine release syndrome.
    Azar MM; Shin JJ; Kang I; Landry M
    Expert Rev Mol Diagn; 2020 Nov; 20(11):1087-1097. PubMed ID: 32990479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relationship between serum levels of interleukin-2 and IL-8 with circulating microRNA-10b in patients with COVID-19.
    Bagheri-Hosseinabadi Z; Ostad Ebrahimi H; Bahrehmand F; Taghipour G; Abbasifard M
    Iran J Immunol; 2021 Mar; 18(1):65-73. PubMed ID: 33787515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased Serum Levels of Soluble TNF-α Receptor Is Associated With ICU Mortality in COVID-19 Patients.
    Mortaz E; Tabarsi P; Jamaati H; Dalil Roofchayee N; Dezfuli NK; Hashemian SM; Moniri A; Marjani M; Malekmohammad M; Mansouri D; Varahram M; Folkerts G; Adcock IM
    Front Immunol; 2021; 12():592727. PubMed ID: 33968010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating furin, IL-6, and presepsin levels and disease severity in SARS-CoV-2-infected patients.
    Kocyigit A; Sogut O; Durmus E; Kanimdan E; Guler EM; Kaplan O; Yenigun VB; Eren C; Ozman Z; Yasar O
    Sci Prog; 2021 Jun; 104(2_suppl):368504211026119. PubMed ID: 34187224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discrimination of COVID-19 From Inflammation-Induced Cytokine Storm Syndromes Using Disease-Related Blood Biomarkers.
    Kessel C; Vollenberg R; Masjosthusmann K; Hinze C; Wittkowski H; Debaugnies F; Nagant C; Corazza F; Vély F; Kaplanski G; Girard-Guyonvarc'h C; Gabay C; Schmidt H; Foell D; Tepasse PR
    Arthritis Rheumatol; 2021 Oct; 73(10):1791-1799. PubMed ID: 33880885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating Levels of Interleukin-6 and Interleukin-10, But Not Tumor Necrosis Factor-Alpha, as Potential Biomarkers of Severity and Mortality for COVID-19: Systematic Review with Meta-analysis.
    Udomsinprasert W; Jittikoon J; Sangroongruangsri S; Chaikledkaew U
    J Clin Immunol; 2021 Jan; 41(1):11-22. PubMed ID: 33128665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum IL-6: A potential biomarker of mortality among SARS-CoV-2 infected patients in Mexico.
    Avila-Nava A; Cortes-Telles A; Torres-Erazo D; López-Romero S; Chim Aké R; Gutiérrez Solis AL
    Cytokine; 2021 Jul; 143():155543. PubMed ID: 33896708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Role of Inflammatory Cytokines (Interleukin-1 and Interleukin-6) as a Potential Biomarker in the Different Stages of COVID-19 (Mild, Severe, and Critical).
    Ghofrani Nezhad M; Jami G; Kooshkaki O; Chamani S; Naghizadeh A
    J Interferon Cytokine Res; 2023 Apr; 43(4):147-163. PubMed ID: 37062817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between disease severity and serum IL-6 levels in COVID-19 anosmia.
    Sanli DET; Altundag A; Kandemirli SG; Yildirim D; Sanli AN; Saatci O; Kirisoglu CE; Dikensoy O; Murrja E; Yesil A; Bastan S; Karsidag T; Akinci IO; Ozkok S; Yilmaz E; Tuzuner F; Kilercik M; Ljama T
    Am J Otolaryngol; 2021; 42(1):102796. PubMed ID: 33152573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytokine profiles in the detection of severe lung involvement in hospitalized patients with COVID-19: The IL-8/IL-32 axis.
    Bergantini L; d'Alessandro M; Cameli P; Otranto A; Luzzi S; Bianchi F; Bargagli E
    Cytokine; 2022 Mar; 151():155804. PubMed ID: 35063722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Longitudinal Cytokine Profile in Patients With Mild to Critical COVID-19.
    Ling L; Chen Z; Lui G; Wong CK; Wong WT; Ng RWY; Tso EYK; Fung KSC; Chan V; Yeung ACM; Hui DSC; Chan PKS
    Front Immunol; 2021; 12():763292. PubMed ID: 34938289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Daily monitoring of viral load measured as SARS-CoV-2 antigen and RNA in blood, IL-6, CRP and complement C3d predicts outcome in patients hospitalized with COVID-19.
    Brasen CL; Christensen H; Olsen DA; Kahns S; Andersen RF; Madsen JB; Lassen A; Kierkegaard H; Jensen A; Sydenham TV; Madsen JS; Møller JK; Brandslund I
    Clin Chem Lab Med; 2021 Nov; 59(12):1988-1997. PubMed ID: 34455731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-6 Is a Biomarker for the Development of Fatal Severe Acute Respiratory Syndrome Coronavirus 2 Pneumonia.
    Santa Cruz A; Mendes-Frias A; Oliveira AI; Dias L; Matos AR; Carvalho A; Capela C; Pedrosa J; Castro AG; Silvestre R
    Front Immunol; 2021; 12():613422. PubMed ID: 33679753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebrospinal fluid and serum interleukins 6 and 8 during the acute and recovery phase in COVID-19 neuropathy patients.
    Manganotti P; Bellavita G; Tommasini V; D Acunto L; Fabris M; Cecotti L; Furlanis G; Sartori A; Bonzi L; Buoite Stella A; Pesavento V
    J Med Virol; 2021 Sep; 93(9):5432-5437. PubMed ID: 33951196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. D-Dimer, Fibrinogen, and IL-6 in COVID-19 Patients with Suspected Venous Thromboembolism: A Narrative Review.
    Eljilany I; Elzouki AN
    Vasc Health Risk Manag; 2020; 16():455-462. PubMed ID: 33223833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.